Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;69(8-9):605-616.
doi: 10.1007/s00251-017-0985-7. Epub 2017 Jul 10.

The roles of MHC class II genes and post-translational modification in celiac disease

Affiliations
Review

The roles of MHC class II genes and post-translational modification in celiac disease

Ludvig M Sollid. Immunogenetics. 2017 Aug.

Abstract

Our increasing understanding of the etiology of celiac disease, previously considered a simple food hypersensitivity disorder caused by an immune response to cereal gluten proteins, challenges established concepts of autoimmunity. HLA is a chief genetic determinant, and certain HLA-DQ allotypes predispose to the disease by presenting posttranslationally modified (deamidated) gluten peptides to CD4+ T cells. The deamidation of gluten peptides is mediated by transglutaminase 2. Strikingly, celiac disease patients generate highly disease-specific autoantibodies to the transglutaminase 2 enzyme. The dual role of transglutaminase 2 in celiac disease is hardly coincidental. This paper reviews the genetic mapping and involvement of MHC class II genes in disease pathogenesis, and discusses the evidence that MHC class II genes, via the involvement of transglutaminase 2, influence the generation of celiac disease-specific autoantibodies.

Keywords: Celiac disease; MHC class II; Post-translational.

PubMed Disclaimer

References

    1. J Immunol. 2015 Jun 15;194(12):6112-22 - PubMed
    1. Int Immunol. 1997 Jun;9(6):905-11 - PubMed
    1. J Autoimmun. 2016 Jun;70:63-72 - PubMed
    1. PLoS One. 2015 Aug 05;10(8):e0134922 - PubMed
    1. J Allergy Clin Immunol. 2017 Mar 8;:null - PubMed

MeSH terms